Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors [Phase 2]
Phase 2 feasibility study evaluating pazopanib in combination with chemotherapy for gynecologic tumors; the trial has completed and results …
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of bevacizumab with carboplatin and paclitaxel in ovarian, fallopian tube, or primary peritoneal cancer; the study was termina…
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Letrozole in Patients With Ovarian Tumors [Phase 2]
Phase 2 trial of letrozole in patients with ovarian tumors (ovarian, fallopian tube, and peritoneal cancer) was terminated with results post…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating the combination of docetaxel and carboplatin in relapsed stage III/IV ovarian epithelial cancer or primary peritone…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the three-drug combination of erlotinib, docetaxel, and carboplatin in newly diagnosed Stage III or Stage IV ova…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial of gemcitabine and topotecan in recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating allogeneic natural killer cells in patients with recurrent ovarian, Fallopian tube, and primary peritoneal cancers;…
-
CLINICAL_TRIALS trial_result · 2010-09-09Clinical Trial Update: An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy [Phase 3]
Phase 3 trial in ovarian, primary peritoneal, or fallopian tube cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-08-12Clinical Trial Update: Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer [Phase 2]
A Phase 2 trial update on consolidation Whole Abdominal IMRT for advanced ovarian cancer, including fallopian tube cancer and primary perito…
-
CLINICAL_TRIALS trial_result · 2010-07-20Clinical Trial Update: A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy [Phase 2]
A phase II trial assessing gefitinib (ZD1839) in combination with tamoxifen for epithelial ovarian cancer, fallopian tube cancer, or periton…
-
CLINICAL_TRIALS trial_result · 2010-05-07Clinical Trial Update: Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial evaluating cellular adoptive immunotherapy for stage III/IV ovarian cancer or primary peritoneal cancer has completed…
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma [Phase 2]
A Phase 2 study sponsored by Eli Lilly in patients with persistent or recurrent epithelial ovarian cancer or primary peritoneal carcinoma ha…
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 2]
Phase II trial evaluating an EGFR-targeted therapy in patients with advanced ovarian, primary peritoneal, and fallopian tube cancers; the st…
-
CLINICAL_TRIALS trial_result · 2009-08-24Clinical Trial Update: A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 study of single-agent pemetrexed disodium in patients with recurrent or persistent ovarian cancer or primary peritoneal cancer; resu…
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial of docetaxel and capecitabine in recurrent or persistent ovarian epithelial cancer, fallopian tube cancer, and peritoneal canc…
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating the combination of topotecan and lapatinib in patients with early recurrent ovarian or peritoneal cancer has been…
-
CLINICAL_TRIALS trial_result · 2008-11-07Clinical Trial Update: A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 study of D4064A for recurrent/persistent epithelial ovarian, primary peritoneal, or fallopian tube cancer is currently suspended.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: SU5416 and Carboplatin to Treat Ovarian Cancer [Phase 1]
A Phase 1 study evaluated SU5416 in combination with carboplatin for ovarian, fallopian tube, and peritoneal cancers; the trial status shows…
-
CLINICAL_TRIALS trial_result · 2008-01-03Clinical Trial Update: Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma [Phase 2]
Phase II trial evaluating a modified triple-doublet therapy in women with newly diagnosed Mullerian carcinomas (ovarian, fallopian tube, or …
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating interferon gamma-1b plus chemotherapy for ovarian cancer and peritoneal cancer was terminated; the update discuss…
-
CLINICAL_TRIALS trial_result · 2007-05-17Clinical Trial Update: Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy [Phase 2]
Phase 2 trial of pemetrexed in patients with ovarian cancer or primary peritoneal cancer after platinum-based chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. [Phase 3]
A Phase 3 randomized trial for platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2006-11-08Clinical Trial Update: Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients [Phase 2]
Phase IIa randomized, multicenter, open-label study to identify the better intraperitoneal dose of Removab (catumaxomab) in platinum-refract…
-
CLINICAL_TRIALS trial_result · 2006-11-07Clinical Trial Update: Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer [Phase 2]
Pfizer-sponsored Phase 2 trial of an oral VEGFR-2 tyrosine kinase inhibitor for small-volume ovarian, peritoneal, and fallopian tube cancers…
-
CLINICAL_TRIALS trial_result · 2006-09-15Clinical Trial Update: Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Gemzar (gemcitabine) and Alimta (pemetrexed) in patients with recurrent platinum-sensit…